Page last updated: 2024-08-23

daunorubicin and Glioma

daunorubicin has been researched along with Glioma in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's6 (42.86)18.2507
2000's0 (0.00)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrows, LR; Ireland, CM; Kokoshka, JM1
Chen, GR; Cheng, L; Gu, LY; Ju, RJ; Li, XT; Liu, S; Song, XL; Wang, X; Xiao, Y; Zhang, SM1
Ju, RJ; Liu, L; Lu, WL; Mu, LM; Xie, HJ; Yan, Y; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y1
Ju, RJ; Li, XT; Li, XY; Liu, L; Lou, JN; Lu, WL; Shi, JF; Sun, MG; Zeng, F; Zhang, CX1
Du, J; Guo, J; Li, RJ; Lou, JN; Lu, WL; Men, Y; Shang, DW; Tian, W; Wen, H; Yang, TY; Ying, X; Zhang, LR; Zhang, Q; Zhang, Y1
Dunn, IS; Haggerty, TJ; Kurnick, JT; Martin, S; Newton, EE; Riley, JL; Rose, LB1
Anton, M; Gänsbacher, B; Haczek, C; Holm, PS; Holzmüller, R; Kasajima, A; Lage, H; Mantwill, K; Rognoni, E; Schlegel, J; Schuster, T; Treue, D; Weichert, W1
Gehan, EA1
Keprtová, J; Kleinwächter, V; Minárová, E; Vyhnáková, M1
Bakker, PJ; Bosch, DA; de Boer, OJ; Kaaijk, P; Leenstra, S; Troost, D; Van Amstel, P1
Huwyler, J; Pardridge, WM; Yang, J1
Boiardi, A; D'Incalci, M; Parisi, I; Piccolrovazzi, S; Silvani, A; Zucchetti, M1
Ames, MM; Kuffel, MJ; Reid, JM1
Robert, J; Schott, B1

Other Studies

14 other study(ies) available for daunorubicin and Glioma

ArticleYear
Cell-based screen for identification of inhibitors of tubulin polymerization.
    Journal of natural products, 1996, Volume: 59, Issue:12

    Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured

1996
Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Aug-30, Volume: 106

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biphenyl Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Daunorubicin; Drug Liberation; Glioma; Lactoferrin; Lignans; Liposomes; Mice, Inbred ICR; Rats

2017
Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells.
    Journal of biomedical nanotechnology, 2016, Volume: 12, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Daunorubicin; Glioma; Liposomes; Male; Mice; Mice, Inbred ICR; Neoplastic Stem Cells; Rats; Signal Transduction; Tissue Distribution

2016
Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells.
    Oncotarget, 2014, Aug-15, Volume: 5, Issue:15

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Daunorubicin; Glioma; Liposomes; Mice; Neoplastic Stem Cells; Quinacrine; Tamoxifen; Wheat Germ Agglutinins

2014
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Jan-25, Volume: 141, Issue:2

    Topics: Aniline Compounds; Animals; Antibiotics, Antineoplastic; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Flow Cytometry; Glioma; Liposomes; Male; Mannosides; Mice; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Time Factors; Transferrin

2010
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.
    Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:1

    Topics: Antigen Presentation; CD8-Positive T-Lymphocytes; Coculture Techniques; Daunorubicin; DNA Topoisomerases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunotherapy; Interferon-gamma; Interleukin-2; Jurkat Cells; Lymphocyte Activation; MART-1 Antigen; Melanoma; Receptors, Antigen, T-Cell; Transgenes

2011
YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
    International journal of cancer, 2011, Sep-01, Volume: 129, Issue:5

    Topics: Adenoviridae; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Blotting, Western; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Dacarbazine; Daunorubicin; Genetic Therapy; Genetic Vectors; Glioma; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Oncolytic Virotherapy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temozolomide; Tumor Cells, Cultured; Virus Replication; Y-Box-Binding Protein 1

2011
Design of controlled clinical trials: use of historical controls.
    Cancer treatment reports, 1982, Volume: 66, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Glioma; Humans; Leukemia; Male; Plicamycin; Random Allocation; Uracil; Vincristine

1982
Effects of daunomycin and its macromolecular analog daunophilin on the proliferation of mammalian cells.
    Neoplasma, 1993, Volume: 40, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Division; Cell Line; Daunorubicin; Dose-Response Relationship, Drug; Female; Glioma; HeLa Cells; Humans; Lung; Methacrylates; Molecular Sequence Data; Rats; Time Factors; Tumor Cells, Cultured

1993
Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
    British journal of cancer, 1996, Volume: 74, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Brain Neoplasms; Carmustine; Cell Division; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Glioma; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Spheroids, Cellular; Tumor Cells, Cultured

1996
Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Daunorubicin; Drug Carriers; Glioma; Liposomes; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Tissue Distribution

1997
Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Brain Neoplasms; Daunorubicin; Drug Carriers; Glioma; Humans; Liposomes; Middle Aged

1999
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:1

    Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1992
Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.
    Biochemical pharmacology, 1989, Nov-15, Volume: 38, Issue:22

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Epirubicin; Glioma; Rats; Tumor Cells, Cultured

1989